Article
A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders
1 Jan 2016
Abstract excerpt
Substance use disorders (SUD) are a major contributor to disability and disease burden worldwide. Risk for developing SUDs is influenced by variation in the genome. Identifying the genetic variants that influence SUD risk may help us to understand the biological mechanisms for the disorders and improve treatments. Genome-wide association studies (GWAS) have been successful in identifying many regions of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
